Ikarian Capital, LLC Neuronetics, Inc. Transaction History
Ikarian Capital, LLC
- $714 Million
- Q1 2025
A detailed history of Ikarian Capital, LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 1,100,000 shares of STIM stock, worth $4.38 Million. This represents 0.57% of its overall portfolio holdings.
Number of Shares
1,100,000Holding current value
$4.38 Million% of portfolio
0.57%Shares
1 transactions
Others Institutions Holding STIM
# of Institutions
103Shares Held
18.7MCall Options Held
96.2KPut Options Held
58.4K-
Vanguard Group Inc Valley Forge, PA2.31MShares$9.18 Million0.0% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$6.92 Million1.44% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.42MShares$5.64 Million0.01% of portfolio
-
Masters Capital Management LLC Atlanta, GA1MShares$3.98 Million0.19% of portfolio
-
Manatuck Hill Partners, LLC Westport, CT920KShares$3.66 Million1.7% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $108M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...